Variations of circulating cardiac biomarkers during and after anthracycline-containing chemotherapy in breast cancer patients

Table 2 Percentage of significant increase in markers levels at each time point of the chemotherapy treatment

Time points	cTnT	NT-proBNP	sST2	miR-126-3p	miR-199a-3p	miR-423-5p	miR-34a-5p
NA2	42%	58%	64%	76%	64%	78%	98%
D8	73%	60%	87%	–	–	78%	89%
3 M	47%	60%	69%	71%	–	73%	89%

ISSN: 1471-2407

Time points	cTnT	NT-proBNP	sST2	miR-126-3p	miR-199a-3p	miR-423-5p	miR-34a-5p
NA2	42%	58%	64%	76%	64%	78%	98%
D8	73%	60%	87%	–	–	78%	89%
3 M	47%	60%	69%	71%	–	73%	89%

Time points	cTnT	NT-proBNP	sST2	miR-126-3p	miR-199a-3p	miR-423-5p	miR-34a-5p
NA2	42%	58%	64%	76%	64%	78%	98%
D8	73%	60%	87%	–	–	78%	89%
3 M	47%	60%	69%	71%	–	73%	89%

Time points	cTnT	NT-proBNP	sST2	miR-126-3p	miR-199a-3p	miR-423-5p	miR-34a-5p
NA2	42%	58%	64%	76%	64%	78%	98%
D8	73%	60%	87%	–	–	78%	89%
3 M	47%	60%	69%	71%	–	73%	89%